Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Published: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in:

Open Access 01-12-2024 | Ribavirin | Research

Crimean-Congo haemorrhagic fever among healthcare workers in Iran 2000–2023, a report of National Reference Laboratory

Authors: Mehdi Fazlalipour, Tahmineh Jalali, Roger Hewson, Mohammad Hassan Pouriayevali, Mostafa Salehi-Vaziri

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Crimean-Congo haemorrhagic fever (CCHF) is a lethal acute viral zoonosis with a case fatality rate of 5–50%. Due to the potential of human-to human transmission of the disease, healthcare workers (HCWs) are at risk of occupational exposure to CCHF virus. Little is known about CCHF virus route of transmission and risks in Iranian HCWs. Therefore this study was designed to identify the routes of exposure to the CCHF virus among Iranian HCWs.

Methods

From Oct 2000 to Feb 2023, 96 CCHF suspected healthcare workers referred to national reference laboratory were tested for CCHF virus infection by the use of RT-PCR and IgM Capture Enzyme-Linked Immunosorbent Assay (MAC-ELISA) and exposure history of cases were investigated to determine the CCHF virus routes of transmission in nosocomial settings.

Results

Twelve CCHF confirmed cases were identified including seven nurses and five physicians, with the median age of 32.5 years (range 23–53 years) and the median incubation period of 6.8 days (range from 1 to 22 days). None of the cases reported a history of tick bite or close contact with tissues or animal blood. The cases were from Razavi Khorasan (seven cases), Sistan and Baluchistan (two cases), Isfahan (one case), South Khorasan (one case) and Fars (one case). Percutaneous exposure (needle stick) (three cases), mucosal exposure (blood splash in to face) (three cases) and skin contact with blood (three cases) constituted the most prevalent routes of transmission. Since 2013, no CCHF cases have been identified among Iranian HCWs.

Conclusions

In healthcare settings, physicians and nurses are at risk of nosocomial CCHF virus infection. The routes of transmission mainly include direct exposures via needle-stick, mucosal or direct contact with the skin to infected blood. Continuous education and implementation of infection prevention and control measures are key factors to minimize the incidence of healthcare related CCHF.
Literature
1.
Ahmadkhani M, et al. Space-time epidemiology of Crimean-Congo hemorrhagic fever (CCHF) in Iran. Ticks Tick Borne Dis. 2018;9(2):207–16.CrossRefPubMed
2.
Maes P, et al. Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018. Arch Virol. 2018;163(8):2295–310.CrossRefPubMed
3.
4.
Bente DA, et al. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100(1):159–89.CrossRefPubMed
5.
Fazlalipour M, et al. Crimean-Congo Hemorrhagic Fever due to consumption of raw meat: Case Reports from East-North of Iran. Jpn J Infect Dis. 2016;69(3):270–1.CrossRefPubMed
6.
7.
8.
Athar MN, et al. Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002: contact tracing and risk assessment. Am J Trop Med Hyg. 2005;72(4):471–3.CrossRefPubMed
9.
Aslani D, et al. Crimean-Congo hemorrhagic fever among children in Iran. Arch Virol. 2017;162(3):721–5.CrossRefPubMed
10.
Salehi-Vaziri M, et al. The First Fatal Case of Crimean-Congo Hemorrhagic Fever caused by the AP92-Like strain of the Crimean-Congo Hemorrhagic Fever Virus. Jpn J Infect Dis. 2016;69(4):344–6.CrossRefPubMed
11.
Mardani M, et al. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg. 2007;76(3):443–5.CrossRefPubMed
12.
Pourahmad M, et al. Nosocomial transmission of Crimean-Congo hemorrhagic fever in a health care worker, Fars Province, Iran. Archives Clin Infect Dis. 2011;6(1):47–50.
13.
Mardani M. Nosocomial crimean-Congo hemorrhagic fever in Iran, 1999–2000. Clin Microbiol Infec. 2001;7(suppl 1):213.
14.
Mardani M, et al. The efficacy of oral Ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clin Infect Dis. 2003;36(12):1613–8.CrossRefPubMed
15.
Russmann S, et al. Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. Curr Med Chem. 2006;13(27):3351–7.CrossRefPubMed
16.
Suleiman MN, et al. Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the Rashid Hospital. Lancet. 1980;2(8201):939–41.CrossRefPubMed
17.
Tutuncu EE, et al. Crimean Congo haemorrhagic fever, precautions and Ribavirin prophylaxis: a case report. Scand J Infect Dis. 2009;41(5):378–80.CrossRefPubMed
18.
Koksal I, et al. The first crimean-Congo hemorrhagic fever case in the winter season from Turkey. Intervirology. 2011;54(3):144–5.CrossRefPubMed
19.
Butenko A, Karganova G. Crimean-Congo hemorrhagic fever in Russia and other countries of the former Soviet Union, in Crimean-Congo hemorrhagic fever. Germany: Springer; 2007. pp. 99–114.
20.
Leblebicioglu H, et al. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002–2014: a multicentre retrospective cross-sectional study. Clin Microbiol Infect. 2016;22(4):e3871–4.CrossRef
21.
22.
Gozel MG, et al. Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus. Int J Infect Dis. 2013;17(11):e1046–50.CrossRefPubMed
23.
Mardani M, et al. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg. 2009;81(4):675–8.CrossRefPubMed
24.
Pshenichnaya NY, Nenadskaya SA. Probable crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster. Int J Infect Dis. 2015;33:120–2.CrossRefPubMed
25.
Johnson S, et al. Ribavirin for treating Crimean Congo haemorrhagic fever. Cochrane Database Syst Rev. 2018;6(6):CD012713.PubMed
26.
D’Addiego J, et al. Investigating the effect of Ribavirin treatment on genetic mutations in Crimean–Congo haemorrhagic fever virus (CCHFV) through next-generation sequencing. J Med Virol. 2023;95(2):e28548.CrossRefPubMed
27.
Leblebicioglu H, et al. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002–2014: a multicentre retrospective cross-sectional study. Clin Microbiol Infect. 2016;22(4):e1-387.e4.CrossRef
28.
Yagci-Caglayik D, et al. Monitoring Crimean-Congo haemorrhagic fever virus RNA shedding in body secretions and serological status in hospitalised patients, Turkey, 2015. Eurosurveillance. 2020;25(10):1900284.CrossRefPubMedPubMedCentral
29.
Hasanoglu I, et al. Dynamics of viral load in Crimean Congo hemorrhagic fever. J Med Virol. 2018;90(4):639–43.CrossRefPubMed
30.
Kaya A, et al. Crimean-Congo hemorrhagic fever disease due to tick bite with very long incubation periods. Int J Infect Dis. 2011;15(7):e449–52.CrossRefPubMed
Metadata
Title
Crimean-Congo haemorrhagic fever among healthcare workers in Iran 2000–2023, a report of National Reference Laboratory
Authors
Mehdi Fazlalipour
Tahmineh Jalali
Roger Hewson
Mohammad Hassan Pouriayevali
Mostafa Salehi-Vaziri
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-10199-1

Other articles of this Issue 1/2024

Correction: Long COVID is not the same for everyone: a hierarchical cluster analysis of long COVID symptoms 9 and 12 months after SARS-CoV-2 test

Factors associated with cellulitis in lymphoedema of the arm – an international cross-sectional study (LIMPRINT)

Epidemiology of Citrobacter spp. infections among hospitalized patients: a systematic review and meta-analysis

Comprehensive analysis of risk factors for postoperative wound infection following open reduction and internal fixation of Rib fractures

Publisher Correction: Chlamydia psittaci Pneumonia in a patient with motor neuron disease: a case report

Language discrepancies in the performance of generative artificial intelligence models: an examination of infectious disease queries in English and Arabic

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits